Pharmasurgics Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
Pharmasurgics General Information
Description
Developer of an anti-scarring and healing treatment after surgery. The company develops and commercializes a novel treatment for preventing harmful scarring and promoting wound healing after surgery. It's product concept is based on proprietary synthetic peptides of human lactoferrin which have strong anti-inflammatory and anti-infectious properties.
Contact Information
Website
pharmasurgics.seCorporate Office
- Arvid Wallgrens Backe 20
- 413 46 Gothenburg
- Sweden
Corporate Office
- Arvid Wallgrens Backe 20
- 413 46 Gothenburg
- Sweden
Pharmasurgics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Nov-2010 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC | 28-May-2008 | Completed | Pre-Clinical Trials |
Pharmasurgics Patents
Pharmasurgics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130310306-A1 | Human lactoferrin derived peptides and their use | Active | 26-Jan-2011 | ||
| WO-2012101157-A1 | Human lactoferrin derived peptides and there use | Inactive | 26-Jan-2011 | ||
| WO-2012101156-A2 | New synthetic peptides and their use | Inactive | 26-Jan-2011 | ||
| WO-2010125069-A1 | Hyaluronic acid for preventing post surgical adhesions | Inactive | 28-Apr-2009 | ||
| JP-2012515151-A | Hyaluronic acid-containing composition for treating wounds, scars, and post-surgical adhesion formation | Active | 13-Jan-2009 | A61K38/40 |
Pharmasurgics Signals
Pharmasurgics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Granitor | Venture Capital | Minority | ||
| KDventures | Venture Capital | Minority | ||
| Östersjöstiftelsen | Limited Partner | Minority |
Pharmasurgics Investments & Acquisitions (4)
Pharmasurgics’s most recent deal was a Merger/Acquisition with LipoPeptide. The deal was made on 31-Dec-2010.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| LipoPeptide | 31-Dec-2010 | Merger/Acquisition | Pharmaceuticals | ||
| DermaGen | 01-Dec-2010 | Merger/Acquisition | Drug Discovery | ||
| XImmune | 01-Jan-2009 | Secondary Transaction - Private | Drug Discovery | ||
| LipoPeptide | Merger/Acquisition | Pharmaceuticals |
Pharmasurgics FAQs
-
When was Pharmasurgics founded?
Pharmasurgics was founded in 2005.
-
Where is Pharmasurgics headquartered?
Pharmasurgics is headquartered in Gothenburg, Sweden.
-
What is the size of Pharmasurgics?
Pharmasurgics has 5 total employees.
-
What industry is Pharmasurgics in?
Pharmasurgics’s primary industry is Medical Supplies.
-
Is Pharmasurgics a private or public company?
Pharmasurgics is a Private company.
-
What is Pharmasurgics’s current revenue?
The current revenue for Pharmasurgics is .
-
How much funding has Pharmasurgics raised over time?
Pharmasurgics has raised $2.84M.
-
Who are Pharmasurgics’s investors?
Granitor, KDventures, and Östersjöstiftelsen have invested in Pharmasurgics.
-
When was Pharmasurgics acquired?
Pharmasurgics was acquired on 01-Nov-2010.
-
Who acquired Pharmasurgics?
Pharmasurgics was acquired by Promore Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process